Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-02
1997-08-05
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540593, A61K 3155, C07D49504
Patent
active
056542976
ABSTRACT:
This invention relates to new bicyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired, such as in congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction.
REFERENCES:
patent: 4766108 (1988-08-01), Ali
patent: 5055448 (1991-10-01), Manning et al.
patent: 5070187 (1991-12-01), Gavras et al.
patent: 5258510 (1993-11-01), Ogawa et al.
J. Med. Chem., 1992,35, 3905-3918, Williams et al.
J. Med. Chem., 1992, 35, 3895-3904--Manning et al.
J. Med. Chem., 1992, 35, 382-388, Manning et al.
From Vasopressin Antagonist to Agonist, DN + P 4 (4), May 1991, Ruffolo et al. pp. 217-221.
Br. J. Pharmacol. (1992), 105, 787-791, Yamamura et al.
Science, vol. 252, pp. 572-574, Yamamura et al. (1991).
J. Med. Chem., 1992, 35, 3919-3927, Evans et al.
J. Med. Chem., 1993, 36, 3993-4005, Evans et al.
Albright Jay D.
Delos Santos Efren G.
American Cyanamid Company
Datlow Philip I.
Eck Steven R.
LandOfFree
Tricyclic thieno-azepine vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic thieno-azepine vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic thieno-azepine vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1074972